HomeCompareMSTX vs MRK

MSTX vs MRK: Dividend Comparison 2026

MSTX yields 73.80% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MSTX wins by $1.20M in total portfolio value
10 years
MSTX
MSTX
● Live price
73.80%
Share price
$19.55
Annual div
$14.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.25M
Annual income
$341,927.37
Full MSTX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MSTX vs MRK

📍 MSTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMSTXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MSTX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MSTX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MSTX
Annual income on $10K today (after 15% tax)
$6,272.87/yr
After 10yr DRIP, annual income (after tax)
$290,638.26/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MSTX beats the other by $282,309.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MSTX + MRK for your $10,000?

MSTX: 50%MRK: 50%
100% MRK50/50100% MSTX
Portfolio after 10yr
$655.1K
Annual income
$175,862.76/yr
Blended yield
26.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MSTX
No analyst data
Altman Z
3.0
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MSTX buys
0
MRK buys
0
No recent congressional trades found for MSTX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMSTXMRK
Forward yield73.80%2.76%
Annual dividend / share$14.43$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.25M$56.8K
Annual income after 10y$341,927.37$9,798.13
Total dividends collected$1.08M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MSTX vs MRK ($10,000, DRIP)

YearMSTX PortfolioMSTX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,080$7,379.85$11,206$366.19+$6.9KMSTX
2$31,815$12,469.78$12,650$502.35+$19.2KMSTX
3$54,550$20,507.61$14,407$694.19+$40.1KMSTX
4$91,230$32,861.71$16,585$967.82+$74.6KMSTX
5$148,979$51,363.03$19,342$1,363.89+$129.6KMSTX
6$237,797$78,388.89$22,913$1,947.19+$214.9KMSTX
7$371,379$116,936.67$27,662$2,823.89+$343.7KMSTX
8$568,054$170,678.44$34,159$4,173.35+$533.9KMSTX
9$851,805$243,987.23$43,337$6,308.80+$808.5KMSTX
10$1,253,359$341,927.37$56,776$9,798.13+$1.20MMSTX

MSTX vs MRK: Complete Analysis 2026

MSTXStock

The Defiance Daily Target 2X Long MSTR ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of MicroStrategy Incorporated (Nasdaq: MSTR). Because the fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds and there is no guarantee that the Fund will meet its stated objective. The fund should not be expected to provide 2 times the cumulative return of MSTR for periods greater than a day.

Full MSTX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MSTX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MSTX vs SCHDMSTX vs JEPIMSTX vs OMSTX vs KOMSTX vs MAINMSTX vs JNJMSTX vs ABBVMSTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.